- Earn up to 24.75 CME credits | ABIM
Overview
Online CME Focus: Substance Use Disorders
Addiction Medicine for Non-Specialists is a comprehensive video CME program geared toward clinicians who see patients with substance use disorders, whether substance use is the primary complaint or not. This collection of thorough and expertly informed lectures will help you more effectively screen, treat, refer, and follow up with these patients.
Led by Antoine Douaihy, MD, experienced practitioners address the need to integrate, prioritize, and personalize care while avoiding harmful stigmas and racial and ethnic disparities. Featured continuing medical education topics include:
- The Pharmacology of Substances of Use
- Gambling Disorders
- Technology Addiction
- Helping Family Members Affected by Substance Use Disorders
- Mindfulness-Based Treatment of Substance Use Disorders
Good to Know: This activity meets the Drug Enforcement Administration (DEA) and Substance Abuse and Mental Health Services Administration (SAMHSA) requirement that as of June 27, 2023, new or renewing DEA registrants must complete a minimum of 8 hours of accredited continuing education (CE) on the treatment and management of patients with opioid or other substance use disorders before renewing their license.
Topics / Speakers
Addiction – An Overview – Antoine Douaihy, MD
Neurobiological Aspects of Substance Use Disorder – Jody Glance, MD
The Epidemiology of Substance Use Disorders – Antoine Douaihy, MD
Screening, Evaluation, and Diagnosis of Substance Use Disorders – Antoine Douaihy, MD
The Pharmacology of Substances of Use – Sharon Connor, MD, and Cassandra Kruse, MD
Management of Intoxication, Withdrawal, and Perioperative Care in Individuals with Substance Use Disorders – Megha Patel, PharmD, BCPS
Alcohol Use Disorder – Julie Kmiec, DO
Stimulant Use Disorder (StUD) – Treatment Overview and Future Therapies – Thersilla Oberbarnscheidt, MD, PhD
Opioid Use Disorder – Julie Kmiec, DO
Benzodiazepine Use and Misuse – Tae Woo Park, MD
Cannabis Use Disorder – Thersilla Oberbarnscheidt, MD
Tobacco Use Disorder – Antoine Douaihy, MD
Chronic Pain and Substance Use Disorders – Amanda Price, MD
Acute Pain and Substance Use Disorder – Julie Wilson Childers, MD
Brief Interventions and Motivational Interviewing for Substance Use Disorders – Cassandra Boness, PhD
Helping Patients with Substance Use Disorders and Co-occurring Psychiatric Psychiatric Disorders (CODs) – Dennis Daley, PhD
The Use of Harm Reduction Strategies with Substance Use Disorders – David Loveland, PhD
Perinatal Substance Use Disorders – Jody Glance, MD
Pharmacotherapy for Adolescents with Substance Use Disorders – Duncan Clark, MD, PhD
Substance Use Disorders in Older Individuals – Katie F. Jones, MD
Healthcare and Racial Disparities in Addiction Treatment – Antoine Douaihy, MD
Medical Complications of Substance Use Disorders including HIV and HCV – Jordi Blanch, MD, PhD
Pain and Opioid Complexity in Individuals with Serious Illness – Varad Deshmukh, MD
The Rise of Gambling Disorder – Significance, Assessment, and Treatment in an Era of Exploding Access – Kavita Fischer, MD
Technology Addiction – Hector Colon-Rivera, MD
Helping Family Members Affected by Substance Use Disorders – Dennis Daley, PhD
Mindfulness-based Treatment of Substance Use Disorders – Antoine Douaihy, MD
Safe and Efficacious Prescribing for Chronic Pain – James R. Latronica, DO, DFASAM
Faculty
Course Director
Antoine Douaihy, MD
Professor of Psychiatry and Medicine
University of Pittsburgh School of Medicine
Pittsburgh, PA
Speakers
Jordi Blanch, MD
Associate Professor
University of Barcelona
Director of Mental Health and Addiction Services
Gestio de Servies Sanitaris, Lleida
Consultant in HIV Psychiatry
Department of Psychiatry and Psychology
Hospital Clinic
Barcelona, Spain
Cassandra Boness, PhD
Assistant Professor
University of New Mexico Department of Psychology & Center on Alcohol, Substance Use, and Addiction
Albuquerque, NM
Julie Wilson Childers, MD
Associate Professor of Medicine
University of Pittsburgh School of Medicine
Pittsburgh, PA
Duncan B. Clark, MD, PhD
Professor of Psychiatry
University of Pittsburgh School of Medicine
Pittsburgh, PA
Hector Colon-Rivera, MD, MVA
Medical Director
Asociación Puertorriqueños en Marcha, Inc. Behavioral Health Program
Philadelphia, PA
Co-Founder and Chief Medical Officer
OKHealth.ai; Co-Founder, CrearConSalud.org
Attending Physician
UPMC Western Psychiatric Hospital
Pittsburgh, PA
Sharon Connor, PharmD
Associate Professor of Pharmacy and Therapeutics
University of Pittsburgh School of Pharmacy
PGY-2 Global Health Ambulatory Care Pharmacy Resident
University of Pittsburgh Medical Center
Pittsburgh, PA
Dennis C. Daley, PhD
Professor of Psychiatry (Adjunct)
University of Pittsburgh
Addiction Medicine Services Consultant
Pressley Ridge, PA
Varad Deshmukh, MD
Assistant Professor of Psychiatry
University of Pittsburgh School of Medicine
Pittsburgh, PA
Kavita Fischer, MD, DFAPA
President Elect
Pennsylvania Psychiatric Society
Regional Medical Director
Community Care Behavioral Health Organization
University of Pittsburgh Medical Center Insurance Services Division
Emergency Department Psychiatrist
Western Psychiatric Hospital
University of Pittsburgh Medical Center
Pittsburgh, PA
Jody Glance, MD
Clinical Chief
Addiction Medicine Services of UPMC Western Behavioral Health
Associate Professor of Psychiatry
University of Pittsburgh School of Medicine
Pittsburgh, PA
Katie Fitzgerald Jones, PhD, ACHPN, CARN-AP
VA Boston Healthcare System
Harvard Medical School
Boston, MA
Julie Kmiec, DO
Associate Professor of Psychiatry
University of Pittsburgh School of Medicine
Addiction Psychiatrist
University of Pittsburgh Medical Center
UPMC Western Psychiatric Hospital
Pittsburgh, PA
Cassandra Kruse, PharmD
PGY-2 Global Health Ambulatory Care Pharmacy Resident
University of Pittsburgh Medical Center
Pittsburgh, PA
James R. Latronica, DO, DFASAM
Chief Medical Officer
Tadiso, Inc.
Pittsburgh, PA
David Loveland, PhD
Science Writer/Editor III
JBS International
North Bethesda, MD
Thersilla Oberbarnscheidt, MD
University of Pittsburgh School of Medicine
UPMC Western Psychiatric Hospital
Pittsburgh, PA
Tae Woo Park, MD
Assistant Professor
Department of Psychiatry
University of Pittsburgh School of Medicine
Pittsburgh, PA
Megha Patel, PharmD, BCPS
UPMC Western Psychiatric Institute
Pittsburgh, PA
Amanda Price, MS, CCRP
Clinical Research Specialist Lead
Department of Psychiatry
University of Michigan Health—Michigan Medicine
Ann Arbor, MI
Accreditation
Oakstone Publishing is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
American Medical Association (AMA)
Oakstone Publishing designates this enduring material for a maximum of 24.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 24.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Date of Original Release: April 30, 2025
Date Credits Expire: April 29, 2028
Estimated Time to Complete: 24.75 hours
CME credit is awarded upon successful completion of a course evaluation and post-test.
Learning Objectives
At the completion of this course, you should be able to:
- Summarize the three main stages of the addiction cycle
- List the signs and symptoms of alcohol withdrawal
- Discuss the epidemiology of opioid use disorder and the medical complications of this disorder
- Summarize the risk factors for benzodiazepine use disorder/misuse
- Explain the toxic effects of cannabis and CBD
- Recognize why and how pain and substance use disorder can co-occur
- Outline the management of acute pain in patients who are prescribed buprenorphine or methadone for opioid use disorder
- Describe culturally, racially, and ethnically informed healthcare
- Name the risk factors and special considerations for women with substance use disorder
- List the brief interventions skills found in OARS
Intended Audience
This educational activity was designed for internists, family physicians, psychiatrists, emergency physicians, PM&R physicians, and neurologists.
SKU: FPV560E0